{"acquisitions":[],"changes":[{"companyHref":"/c/calderatx-com","date":"2026-10-03","documentUrl":"https://atlasventure.com/portfolio/","domain":"calderatx.com","fact":"provenance:existence","name":"Caldera Therapeutics, Inc.","new":{"publisher":"Atlas Venture","status":"sourced","url":"https://atlasventure.com/portfolio/"},"old":{"publisher":"calderatx.com","status":"self-reported","url":"https://calderatx.com"},"publisher":"Atlas Venture","reason":null,"retrievedAt":"2026-10-03","slug":"calderatx-com","status":"sourced","url":"https://whoraisedwhat.com/c/calderatx-com"},{"companyHref":"/c/calderatx-com","date":"2026-09-30","documentUrl":"https://atlasventure.com/portfolio/","domain":"calderatx.com","fact":"provenance:investor:atlas-venture","name":"Caldera Therapeutics, Inc.","new":{"publisher":"Atlas Venture","status":"sourced","url":"https://atlasventure.com/portfolio/"},"old":{"publisher":null,"status":"unknown","url":null},"publisher":"Atlas Venture","reason":null,"retrievedAt":"2026-09-30","slug":"calderatx-com","status":"sourced","url":"https://whoraisedwhat.com/c/calderatx-com"},{"companyHref":"/c/calderatx-com","date":"2026-09-25","documentUrl":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml","domain":"calderatx.com","fact":"latest round","name":"Caldera Therapeutics, Inc.","new":{"amountUsd":37500000,"date":"2026-01-08","lead":null,"type":null},"old":{"amountUsd":37500000,"date":"2026-01-08","lead":null,"type":"seed"},"publisher":"SEC EDGAR","reason":null,"retrievedAt":"2026-09-25","slug":"calderatx-com","status":"sourced","url":"https://whoraisedwhat.com/c/calderatx-com"},{"companyHref":"/c/calderatx-com","date":"2026-09-25","documentUrl":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml","domain":"calderatx.com","fact":"provenance:round","name":"Caldera Therapeutics, Inc.","new":{"publisher":"SEC EDGAR","status":"sourced","url":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml"},"old":{"publisher":"sec-edgar","status":"attributed","url":null},"publisher":"SEC EDGAR","reason":null,"retrievedAt":"2026-09-25","slug":"calderatx-com","status":"sourced","url":"https://whoraisedwhat.com/c/calderatx-com"}],"country":"US","description":"Caldera Therapeutics is a clinical-stage biotech developing the first-in-class bispecific antibody CLD-423 for inflammatory bowel disease and other inflammatory conditions. It targets patients and clinicians facing IBD that has plateaued on single-target therapies. Its differentiator is hitting two validated pathways, IL-23p19 and TL1A, in one molecule.","domain":"calderatx.com","employees":null,"founded":2025,"fundingTotalQuarantined":false,"githubOrg":"calderatx","githubStars":null,"industry":"unknown","industrySources":[],"investors":["atlas-venture"],"lat":42.365635,"lng":-71.104002,"location":"Cambridge, Massachusetts","multiples":[],"name":"Caldera Therapeutics, Inc.","people":[{"name":"Aaron Royston","role":"director","slug":"aaron-royston"},{"name":"Michael Gladstone","role":"director","slug":"michael-gladstone"},{"name":"Michelle Doig","role":"director","slug":"michelle-doig"},{"name":"Praveen Tipirneni","role":"director","slug":"praveen-tipirneni"},{"name":"Praveen Tipirneni","role":"executive","slug":"praveen-tipirneni"},{"name":"Xiaodi Su","role":"director","slug":"xiaodi-su"}],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":37500000,"connectionsAmong":[{"a":"p/aaron-royston","b":"p/michael-gladstone","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/calderatx-com"},{"a":"p/aaron-royston","b":"p/michael-gladstone","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml"}],"since":"2026-01-21","type":"worked_with","via":"c/calderatx-com"},{"a":"p/aaron-royston","b":"p/michelle-doig","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/calderatx-com"},{"a":"p/aaron-royston","b":"p/michelle-doig","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml"}],"since":"2026-01-21","type":"worked_with","via":"c/calderatx-com"},{"a":"p/aaron-royston","b":"p/praveen-tipirneni","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/calderatx-com"},{"a":"p/aaron-royston","b":"p/praveen-tipirneni","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml"}],"since":"2026-01-21","type":"worked_with","via":"c/calderatx-com"},{"a":"p/aaron-royston","b":"p/xiaodi-su","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/calderatx-com"},{"a":"p/aaron-royston","b":"p/xiaodi-su","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml"}],"since":"2026-01-21","type":"worked_with","via":"c/calderatx-com"},{"a":"p/michael-gladstone","b":"p/michelle-doig","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/calderatx-com"},{"a":"p/michael-gladstone","b":"p/michelle-doig","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml"}],"since":"2026-01-21","type":"worked_with","via":"c/calderatx-com"},{"a":"p/michael-gladstone","b":"p/praveen-tipirneni","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/calderatx-com"},{"a":"p/michael-gladstone","b":"p/praveen-tipirneni","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml"}],"since":"2026-01-21","type":"worked_with","via":"c/calderatx-com"},{"a":"p/michael-gladstone","b":"p/xiaodi-su","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/calderatx-com"},{"a":"p/michael-gladstone","b":"p/xiaodi-su","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml"}],"since":"2026-01-21","type":"worked_with","via":"c/calderatx-com"},{"a":"p/michelle-doig","b":"p/praveen-tipirneni","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/calderatx-com"},{"a":"p/michelle-doig","b":"p/praveen-tipirneni","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml"}],"since":"2026-01-21","type":"worked_with","via":"c/calderatx-com"},{"a":"p/michelle-doig","b":"p/xiaodi-su","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/calderatx-com"},{"a":"p/michelle-doig","b":"p/xiaodi-su","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml"}],"since":"2026-01-21","type":"worked_with","via":"c/calderatx-com"},{"a":"p/praveen-tipirneni","b":"p/xiaodi-su","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml"}],"since":null,"type":"board","via":"c/calderatx-com"},{"a":"p/praveen-tipirneni","b":"p/xiaodi-su","documents":[{"publisher":"SEC EDGAR","retrievedAt":"2026-09-28","url":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml"}],"since":"2026-01-21","type":"worked_with","via":"c/calderatx-com"}],"currency":"USD","date":"2026-01-08","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-25","url":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml"},"name":"Aaron Royston","role":"director","roleAsStated":"Director","slug":"aaron-royston"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-25","url":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml"},"name":"Michael Gladstone","role":"director","roleAsStated":"Director","slug":"michael-gladstone"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-25","url":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml"},"name":"Michelle Doig","role":"director","roleAsStated":"Director","slug":"michelle-doig"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-25","url":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml"},"name":"Praveen Tipirneni","role":"director","roleAsStated":"Director","slug":"praveen-tipirneni"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-25","url":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml"},"name":"Praveen Tipirneni","role":"executive","roleAsStated":"Executive Officer","slug":"praveen-tipirneni"},{"document":{"publisher":"SEC EDGAR","retrievedAt":"2026-09-25","url":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml"},"name":"Xiaodi Su","role":"director","roleAsStated":"Director","slug":"xiaodi-su"}],"slug":"calderatx-com-2026-01-08-round","source":{"fact":"round","publisher":"SEC EDGAR","retrievedAt":"2026-09-25","status":"sourced","url":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml"},"status":"sourced","type":null,"url":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml"}],"slug":"calderatx-com","sources":[{"fact":"round","publisher":"SEC EDGAR","retrievedAt":"2026-09-25","status":"sourced","url":"https://www.sec.gov/Archives/edgar/data/2069936/000206993626000001/primary_doc.xml"},{"fact":"existence","publisher":"Atlas Venture","retrievedAt":"2026-10-03","status":"sourced","url":"https://atlasventure.com/portfolio/"},{"fact":"description","publisher":"calderatx.com","retrievedAt":"2026-10-03","status":"self-reported","url":"https://calderatx.com"},{"fact":"investor:atlas-venture","publisher":"Atlas Venture","retrievedAt":"2026-09-30","status":"sourced","url":"https://atlasventure.com/portfolio/"}],"stage":null,"stockCard":{"asOf":"2026-11-09","facts":[{"id":"investor:{\"actorKind\": \"investor\", \"name\": \"Atlas Venture\", \"role\": \"portfolio\", \"slug\": \"atlas-venture\", \"sources\": [{\"publisher\": \"Atlas Venture\", \"retrievedAt\": \"2026-09-30\", \"status\": \"sourced\", \"url\": \"https://atlasventure.com/portfolio/\"}]}","kind":"investor","sources":[{"publisher":"Atlas Venture","retrievedAt":"2026-09-30","status":"sourced","url":"https://atlasventure.com/portfolio/"}],"text":"Caldera Therapeutics, Inc. was listed in Atlas Venture's portfolio, recorded 2026-09-30."}],"generatedAt":"2026-11-09","investors":[{"actorKind":"investor","name":"Atlas Venture","role":"portfolio","slug":"atlas-venture","sources":[{"publisher":"Atlas Venture","retrievedAt":"2026-09-30","status":"sourced","url":"https://atlasventure.com/portfolio/"}]}],"state":"insufficient-evidence","tldr":[]},"techStack":["Typekit","Adobe Fonts","Afterpay","Sentry","Spin.js","Squarespace","Squarespace Commerce","Stimulus","parallax.js","web-vitals","moment 0","@sentry/browser"],"totalRaisedUsd":37500000,"traction":[],"updatedAt":"2026-10-03","valuations":[]}